KARBINAL

Welcome to the Brand page for “KARBINAL”, which is offered here for Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses;.

Its status is currently believed to be active. Its class is unavailable. “KARBINAL” is believed to be currently owned by “TRIS PHARMA, INC”.


Owner:
TRIS PHARMA, INC
Owner Details
Description:
Oral modified release, extended release, and/or sustained release pharmaceutical preparations for the drug carbinoxamine, a pharmaceutically acceptable salt thereof and/or carbinoxamine polistirex, intended for the treatment of seasonal and perennial allergic rhinitis, and other approved uses;
Categories: ORAL MODIFIED RELEASE